An Update on the SARS-CoV-2 Pandemic and the Lessons It May Teach Us

‍Current evolutionary dynamics

The currentevolutionary dynamics of the SARS-CoV-2 (SC-2) pandemic are characterized by:

• A chronic rather than self-limiting     evolutionary process, in which repeated vaccine-breakthrough     infections (VBTIs) and recurrent viral exposure promote prolonged viral     persistence in susceptible hosts, thereby fostering intra-host evolution,     the emergence of highly mutated saltation variants, and persistent     post-acute sequelae (Long Covid) rather than predominantly acute     severe Covid-19 (C-19).
• Prolonged co-circulation of several     genetically distinct immune escape lineages that     increasingly converge toward similar functional phenotypes enhancing viral     transmission, yet without any lineage consistently acquiring a decisive     competitive advantage. Consequently, fluctuations in their relative     prevalence increasingly depend on subtle demographic, geographic,     seasonal, behavioral or vaccination-related differences rather than on     major intrinsic fitness advantages.
• A gradual shift in the adaptive landscape, reflected by increasing accumulation of mutations in conserved     Spike (S) epitopes as well as in non-S proteins (e.g., ORF7/ORF8),     together with an increasing relative contribution of infections in     specific demographic groups, particularly young children, within highly     C-19-vaccinated populations.

Evidence of a narrowing evolutionary corridor

Despite substantial genotypic divergence amongcurrently circulating SC-2 lineages, their phenotypic characteristicsincreasingly converge while the incremental fitness gains obtained fromconventional amino-acid substitutions become increasingly marginal.

Even large evolutionary jumps in S sequence ─asobserved in BA.3.2-derived lineages─ combined with increasing diversificationin conserved epitopes and non-S proteins, even when combined with a shift ofSC-2 infections to more vulnerable populations (i.e., young children), havethus far failed to restore the type of rapid selective sweeps that are requiredto sustain viral transmission and characterized earlier phases of the pandemic.
These observations suggest that conventional amino-acid-based immune escape maybe approaching diminishing evolutionary returns. Should this trend continue,natural selection may increasingly favor alternative adaptive strategiescapable of fundamentally altering early virus-host interactions rather thanmerely modifying antigenic epitopes.
The most plausible mechanism is extensive remodeling of S glycosylation ─particularlythrough additional O-linked glycosylation sites─ which could substantiallyalter viral phenotype by simultaneously enabling several distinct mechanisms(see section VI below; https://www.voiceforscienceandsolidarity.org/scientific-blog/predictions-gvb-on-evolution-c-19-pandemic).

Such phenotypic innovations would likely carry a significant intrinsic fitnesscost under ordinary circumstances. However, under sufficiently strongpopulation-level immune selection pressure, they could nevertheless acquire adecisive competitive advantage as they would enable full-fledged viralreplication and transmission, regardless of the current viral and immunologicallandscape in highly C-19-vaccinated populations.

Ametastable evolutionary equilibrium

In highly C-19-vaccinated populations, theresulting evolutionary constraints generate an increasingly heterogeneous virallandscape characterized by:

• prolonged coexistence of multiple unrelated variant families with     alternating dominance;
• regional differences in lineage prevalence;
• heterogeneous age distribution of infections;
• recurrent, highly divergent saltation events;
• convergent functional evolution despite genetic diversification.

Taken together, these observations suggestthat SC-2 is evolving within an increasingly constrained adaptive landscape. Ratherthan indicating stable endemicity, I interpret this situation as a metastable evolutionary equilibrium.

Prolonged co-circulation under narrowing evolutionary constraints mayeventually create the prerequisites for a major evolutionary phase transition,which I have termed Hi-Vi-Cron.
Rather than representing the next incremental immune escape variant, such aphenotype would fundamentally alter the interaction between virus and hostimmunity, thereby triggering unconstrained viral replication and transmissionwithin highly C-19-vaccinated populations (https://voiceforscienceandsolidarity.substack.com/p/the-evolutionary-legacy-of-mass-covid).

Which lessons,in my opinion, will be learned once my predictions materialize?

I.      The apparent epidemiological calm ─characterized by diminishedtransmission, delayed viral spread and lack of viral dominance, as well as a shiftfrom acute epidemic waves toward prolonged infection─ is not to beconsidered evidence that the virus is approaching endemic equilibrium.
Rather, these features reflect increasing evolutionary constraint.

II.    As immune escape variants continue competing within an increasinglyrestricted adaptive space, conventional transmissibility-enhancing mutations convergeand yield progressively smaller returns.

Under such conditions, natural selectioneventually favors an entirely different coronavirus phenotype capableof bypassing collective vaccine-primed adaptive immunity instead ofcontinuing to optimize conventional immune escape.
Such CoV phenotype uses an unconditioned fitness advantage to overcomeits conditioned immune environment.

III.  Population-level adaptive immunity that reduces disease severity withoutgenerating transmission-curtailing herd immunity perpetuates viral circulationwhile continuously reshaping the selective landscape that drives further viraladaptation. It thereby paves the way for the virus to transition to a newphenotype capable of breaking through vaccine-primed adaptive immunity inhighly C-19-vaccinated populations instead of driving the pandemic towardendemicity.

IV.   The longer an acute, self-limiting virus struggles to maintaintransmission under increasing but suboptimal immune pressure, the moreheterogeneous both the viral landscape and the demographic distribution ofinfections become.

Such increasing heterogeneity is not evidence of stability but may insteadreflect growing evolutionary constraint.

V.      The higher the prevalence of vaccine-primed adaptiveimmune responses in a highly C-19-vaccinated population, the greater thelikelihood that, within a given time frame, the resulting suboptimalpopulation-level immune pressure will drive natural selection of afundamentally different CoV phenotype capable of effectively circumventingcollective immune pressure on viral transmission and thereby restoring viralfitness.

VI.   As the adaptive landscape becomes increasingly constrained, additionalmutations in conserved S epitopes or in non-S proteins provide progressivelysmaller and less consistent fitness gains. When the population-level immune selectionpressure reaches a bottleneck in its ability to drive the emergence of SC-2variants with a clear and sustained competitive fitness advantage, viralevolution no longer relies on immune escape through amino-acid substitutions inimmunologically relevant S-associated peptide epitopes. Instead, continuedimmune pressure on viral transmission eventually favors a qualitativelydifferent class of adaptive solutions. This phase transition involvesremodeling of the S glycan shield[i].Rather than simply altering antigenicity, a such transition fundamentallyreshapes the early virus-host interaction by simultaneously:

·  bypassing critical adaptive immune targets from pre-existing antibodyand vaccine-primed T-cell recognition;

·  enhancing viral attachment and entry into susceptible host cells;

·  promoting lectin-mediated trans infection;

·  facilitating fusion between infected and non-infected host cells,thereby enabling syncytium formation and enhancing cell-to-cell spread

·  and thereby abolishing dependence on evolutionary pathways currentlyconstrained by increasingly broad vaccine-primed adaptive immune pressure.

Unlike conventional amino-acid-mediated immuneescape, this strategy represents a genuine phenotypic innovation,enabling the virus to circumvent rather than continuously fine-tune itsinteraction with the prevailing adaptive immune landscape. As mentioned above, I have referred to thispredicted phenotype as Hi-Vi-Cron.

During this prolonged period of constrainedevolution yielding diminishing fitness gains, the apparent epidemiological ‘calm’creates the illusion that the pandemic has entered a stable endemic phase.

However, this apparent stability (i.e., metastability) reflects an increasinglyunstable equilibrium in which evolutionary constraints continue to accumulatewhile conventional adaptive pathways become progressively exhausted.

The absence of large epidemic waves should therefore not be interpretedas evidence that the evolutionary process has come to an end, but rather as an indicationthat the system is approaching a critical transition.
Because all of this stands in diametricalopposition to the interpretation advanced by our public-health authorities andleading ‘experts’, I maintain that societies in highly C-19-vaccinatedpopulations will be caught completely off guard.

VII.  Hi-Vi-Cron’s principal competitive advantage no longer arises fromincremental antigenic escape but from its ability to functionally sidelinepre-existing vaccine-primed adaptive immunity.
By relying increasingly on glycan-mediated immune shielding, enhanced viralentry, trans infection, and efficient cell-to-cell dissemination,Hi-Vi-Cron abolishes the effectiveness of both anti-S neutralizing antibodiesand S-directed cell-mediated immune responses.

Thisenables unconstrained viral replication and transmission in highlyC-19-vaccinated populations.

Rather than representing merely another immune escape variant, Hi-Vi-Cronconstitutes a fundamentally new evolutionary strategy ─one capable ofterminating the current metastable host-virus equilibrium by replacing gradual,incremental adaptation with a qualitative evolutionary phase transition; thelatter changes the rules of the evolutionary game by adopting a fundamentallydifferent adaptive strategy. In doing so, it exhibits high virulencewhile acquiring a decisive competitive advantage over all currently circulatingSC-2 lineages that have thus far evolved under the constraints imposed bycollective, vaccine-primed immune pressure.

[i] presumably through the acquisition of additional O-linkedglycosylation sites or other glycan-mediated structural innovations (https://voiceforscienceandsolidarity.substack.com/p/the-evolutionary-legacy-of-mass-covid)

‍